Status: current, Defined. Date: 31-Mar 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3728871000168113 | Irbesartan HCTZ 150/12.5 (Apo) (hydrochlorothiazide 12.5 mg + irbesartan 150 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3728881000168111 | Irbesartan HCTZ 150/12.5 (Apo) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 467551000036119 | Irbesartan HCTZ 150/12.5 (Apo) (hydrochlorothiazide 12.5 mg + irbesartan 150 mg) film-coated tablet (trade product unit of use) | en | Fully specified name | Inactive | Case sensitive | Australian Medicines Terminology module |
| 467561000036116 | Irbesartan HCTZ 150/12.5 (Apo) film-coated tablet | en | Synonym | Inactive | Case sensitive | Australian Medicines Terminology module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Irbesartan HCTZ 150/12.5 (Apo) tablet, 30 | has TPUU | True | Irbesartan HCTZ 150/12.5 (Apo) tablet | Inferred relationship | Some | 1 |
| Irbesartan HCTZ 150/12.5 (Apo) tablet, 30, blister pack | has TPUU | True | Irbesartan HCTZ 150/12.5 (Apo) tablet | Inferred relationship | Some | 1 |
| Irbesartan HCTZ 150/12.5 (Apo) tablet, 30, bottle | has TPUU | True | Irbesartan HCTZ 150/12.5 (Apo) tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set